Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel m-fluoroaniline route for Hepatitis C intermediate. High yield, low cost, scalable process for global pharma supply chains.
Patent CN113024399A details a novel Duff reaction route for high-purity Telmisartan intermediates, offering significant cost reduction and scalable production capabilities.
Patent CN114105858B reveals green electrochemical route for 3-azidoindoline. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN104016974A details a novel synthetic route for Azilsartan medoxomil intermediates, offering high purity and significant cost reduction opportunities for pharmaceutical manufacturing supply chains.
Discover a novel 3-step synthesis for Lenalidomide intermediates using glutarimide. Achieve high purity and significant cost reduction in pharma manufacturing with scalable routes.
Patent CN115368217A details a novel synthesis of 3,4,5-trimethoxytoluene for CoQ10 production, offering significant cost reduction and environmental benefits.
Novel regioselective coupling process for LRRK2 inhibitors offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN114044813B details high-yield procatide preparation offering supply chain stability and significant cost reduction in API manufacturing for global partners.
Novel chiral catalyst method reduces cost and complexity in sitagliptin manufacturing, ensuring high purity and supply chain stability for global pharmaceutical partners.
Patent CN116121310A reveals a high-efficiency enzymatic route for dexketoprofen, offering superior purity and scalable production for reliable pharmaceutical intermediates suppliers.
Novel pH-controlled hydrogenation method ensures high purity and scalable production for pharmaceutical intermediates supply chains globally reducing costs significantly and improving efficiency.
Patent CN103172522A details a one-step nickel-catalyzed hydrogenation method for diaminodecalin, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114438532A reveals a green electrochemical method for deoxydeuteration. Enables cost reduction in API manufacturing with high purity and scalability.
Novel patent CN116041358B details improved Pranoprofen synthesis reducing impurities and temperature constraints for cost-effective pharmaceutical manufacturing supply chains.
Patent CN116730810A reveals high-yield synthesis for steroid intermediates. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN108774271A introduces stable ferrocene ligands for S-configuration alcohols. Enhances supply chain reliability and reduces manufacturing costs for pharma intermediates.
Patent CN103319482B enables mild synthesis of pharmaceutical intermediates. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN114230568B details a high-yield 4-step route for HER2 inhibitor Tucatinib using Pd(acac)2, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN114230568B reveals a high-yield route for HER2 inhibitor Tucatinib. Discover cost-effective manufacturing and scalable purification strategies for pharma intermediates.
Patent CN104292293A reveals high-purity Dutasteride Impurity I synthesis. Enables cost reduction in Pharmaceutical Intermediates manufacturing with scalable processes.